BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 38061987)

  • 21. A Coumarin-Donepezil Hybrid as a Blood-Brain Barrier Permeable Dual Cholinesterase Inhibitor: Isolation, Synthetic Modifications, and Biological Evaluation of Natural Coumarins.
    Sharma A; Nuthakki VK; Gairola S; Singh B; Bharate SB
    ChemMedChem; 2022 Sep; 17(18):e202200300. PubMed ID: 35892288
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Synthesis and evaluation of Fmoc-amino esters and amides bearing a substrate like quaternary ammonium group as selective butyrylcholinesterase inhibitors.
    Godinez J; Lee CY; Schwans JP
    Bioorg Med Chem Lett; 2023 Aug; 92():129392. PubMed ID: 37364726
    [TBL] [Abstract][Full Text] [Related]  

  • 23. 2-Oxoquinoline-based-thiosemicarbazones as multitargeting neurotherapeutics against Alzheimer's disease: In vitro and in silico studies of MAO and ChE inhibitors.
    Basri R; Fatima S; Jalil S; Imran A; Fatima N; Syed A; Bahkali AH; Iqbal J; Shafiq Z
    Arch Pharm (Weinheim); 2023 Nov; 356(11):e2300430. PubMed ID: 37718357
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Localization and properties of cholinesterases in the common prawn (Palaemon serratus): A kinetic-histochemical study.
    Frasco MF; Erzen I; Stojan J; Guilhermino L
    Biol Bull; 2010 Feb; 218(1):1-5. PubMed ID: 20203248
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cholinesterase activity in the plaques, tangles and angiopathy of Alzheimer's disease does not emanate from amyloid.
    Geula C; Greenberg BD; Mesulam MM
    Brain Res; 1994 May; 644(2):327-30. PubMed ID: 8050043
    [TBL] [Abstract][Full Text] [Related]  

  • 26. New cholinesterase inhibitors for Alzheimer's disease: Structure activity relationship, kinetics and molecular docking studies of 1-butanoyl-3-arylthiourea derivatives.
    Larik FA; Shah MS; Saeed A; Shah HS; Channar PA; Bolte M; Iqbal J
    Int J Biol Macromol; 2018 Sep; 116():144-150. PubMed ID: 29729344
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Design, synthesis and evaluation of novel tacrine-coumarin hybrids as multifunctional cholinesterase inhibitors against Alzheimer's disease.
    Xie SS; Wang XB; Li JY; Yang L; Kong LY
    Eur J Med Chem; 2013 Jun; 64():540-53. PubMed ID: 23685572
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Novel cannabidiol-carbamate hybrids as selective BuChE inhibitors: Docking-based fragment reassembly for the development of potential therapeutic agents against Alzheimer's disease.
    Jiang X; Zhang Z; Zuo J; Wu C; Zha L; Xu Y; Wang S; Shi J; Liu XH; Zhang J; Tang W
    Eur J Med Chem; 2021 Nov; 223():113735. PubMed ID: 34371367
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Fluoxetine and sertraline based multitarget inhibitors of cholinesterases and monoamine oxidase-A/B for the treatment of Alzheimer's disease: Synthesis, pharmacology and molecular modeling studies.
    Nadeem MS; Khan JA; Rashid U
    Int J Biol Macromol; 2021 Dec; 193(Pt A):19-26. PubMed ID: 34687762
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Time-course of human cholinesterases-catalyzed competing substrate kinetics.
    Mukhametgalieva AR; Aglyamova AR; Lushchekina SV; Goličnik M; Masson P
    Chem Biol Interact; 2019 Sep; 310():108702. PubMed ID: 31247192
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Multipotent MAO and cholinesterase inhibitors for the treatment of Alzheimer's disease: synthesis, pharmacological analysis and molecular modeling of heterocyclic substituted alkyl and cycloalkyl propargyl amine.
    Samadi A; de los Ríos C; Bolea I; Chioua M; Iriepa I; Moraleda I; Bartolini M; Andrisano V; Gálvez E; Valderas C; Unzeta M; Marco-Contelles J
    Eur J Med Chem; 2012 Jun; 52():251-62. PubMed ID: 22503231
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Correlation between concentration of cholinesterases and the resistance of animals to organophosphorus compounds.
    Ivanov P; Georgiev B; Kirov K; Venkov L
    Drug Chem Toxicol; 1993; 16(1):81-99. PubMed ID: 8436078
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Characterization of O,O-diethylphosphoryl oximes as inhibitors of cholinesterases and substrates of phosphotriesterases.
    Leader H; Vincze A; Manisterski B; Rothschild N; Dosoretz C; Ashani Y
    Biochem Pharmacol; 1999 Aug; 58(3):503-15. PubMed ID: 10424771
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Biochemical differentiation of cholinesterases from normal and Alzheimer's disease cortex.
    Ciro A; Park J; Burkhard G; Yan N; Geula C
    Curr Alzheimer Res; 2012 Jan; 9(1):138-43. PubMed ID: 21244353
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Potential anti-cholinesterase and β-site amyloid precursor protein cleaving enzyme 1 inhibitory activities of cornuside and gallotannins from Cornus officinalis fruits.
    Bhakta HK; Park CH; Yokozawa T; Tanaka T; Jung HA; Choi JS
    Arch Pharm Res; 2017 Jul; 40(7):836-853. PubMed ID: 28589255
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cholinesterases: new roles in brain function and in Alzheimer's disease.
    Giacobini E
    Neurochem Res; 2003 Apr; 28(3-4):515-22. PubMed ID: 12675140
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Synthesis and biological evaluation of a new series of ebselen derivatives as glutathione peroxidase (GPx) mimics and cholinesterase inhibitors against Alzheimer's disease.
    Luo Z; Liang L; Sheng J; Pang Y; Li J; Huang L; Li X
    Bioorg Med Chem; 2014 Feb; 22(4):1355-61. PubMed ID: 24461494
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Neurological cholinesterases in the normal brain and in Alzheimer's disease: relationship to plaques, tangles, and patterns of selective vulnerability.
    Wright CI; Geula C; Mesulam MM
    Ann Neurol; 1993 Sep; 34(3):373-84. PubMed ID: 8363355
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Design, synthesis, biological evaluation, and molecular dynamics of novel cholinesterase inhibitors as anti-Alzheimer's agents.
    Shamsimeymandi R; Pourshojaei Y; Eskandari K; Mohammadi-Khanaposhtani M; Abiri A; Khodadadi A; Langarizadeh A; Sharififar F; Amirheidari B; Akbarzadeh T; Lotfian H; Foroumadi A; Asadipour A
    Arch Pharm (Weinheim); 2019 Jul; 352(7):e1800352. PubMed ID: 31136018
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Brain cholinesterases: III. Future perspectives of AD research and clinical practice.
    Shen ZX
    Med Hypotheses; 2004; 63(2):298-307. PubMed ID: 15236794
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.